Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of 9.00% is 105% above its 5-year average of 4.38%, near the high end of its 5-year range (-460.55%–12.25%).
9.30% above its 12-month average of 8.23%.
Reported quarterly operating margin; no daily interpolation. Q1 FY2027 (2026-06-30): 11.69%.
OPERATING MARGIN
9.00%
OPERATING MARGIN AVG TTM
8.23%
OPERATING MARGIN AVG 3Y
5.57%
OPERATING MARGIN AVG 5Y
4.38%
OPERATING MARGIN AVG 10Y
8.02%
OPERATING MARGIN AVG 15Y
13.69%
OPERATING MARGIN AVG 20Y
18.71%
CURRENT VS TTM AVG
+9.30%
CURRENT VS 3Y AVG
+61.57%
CURRENT VS 5Y AVG
+105.43%
CURRENT VS 10Y AVG
+12.25%
CURRENT VS 15Y AVG
-34.27%
CURRENT VS 20Y AVG
-51.90%
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 598 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Mesa Laboratories, Inc.
Market Cap
$766.58M
Operating Margin
9.00%
TTM Avg
8.23%
3Y Avg
5.57%
5Y Avg
4.38%
Market Cap
$768.46M
Operating Margin
-98.21%
TTM Avg
-366.21%
3Y Avg
-21871.64%
5Y Avg
-19485.10%
Market Cap
$773.03M
Operating Margin
-29.28%
TTM Avg
-127.46%
3Y Avg
-26333.62%
5Y Avg
-23986.43%
Market Cap
$755.39M
Operating Margin
-4974.74%
TTM Avg
-2487.37%
3Y Avg
-2487.37%
5Y Avg
-2487.37%
Market Cap
$748.55M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$744.51M
Operating Margin
-21.60%
TTM Avg
-15.14%
3Y Avg
-11.45%
5Y Avg
-3.99%
Market Cap
$788.78M
Operating Margin
9.86%
TTM Avg
12.61%
3Y Avg
-6.26%
5Y Avg
-239.99%
Market Cap
$743.69M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
-6934.80%
5Y Avg
-9894.67%
Market Cap
$792.17M
Operating Margin
-0.31%
TTM Avg
6.92%
3Y Avg
0.39%
5Y Avg
2.91%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Mesa Laboratories, Inc. (MLAB) | $766.58M | 9.00% | 8.23% | 5.57% | 4.38% |
| Lexicon Pharmaceuticals, Inc. (LXRX)vs › | $768.46M | -98.21% | -366.21% | -21871.64% | -19485.10% |
| Geron Corporation (GERN)vs › | $773.03M | -29.28% | -127.46% | -26333.62% | -23986.43% |
| Attovia Therapeutics, Inc. (ATTO)vs › | $755.39M | -4974.74% | -2487.37% | -2487.37% | -2487.37% |
| Design Therapeutics, Inc. (DSGN)vs › | $748.55M | 0.00% | 0.00% | 0.00% | 0.00% |
| Cytek Biosciences, Inc. (CTKB)vs › | $744.51M | -21.60% | -15.14% | -11.45% | -3.99% |
| Gyre Therapeutics, Inc. (GYRE)vs › | $788.78M | 9.86% | 12.61% | -6.26% | -239.99% |
| Candel Therapeutics, Inc. (CADL)vs › | $743.69M | 0.00% | 0.00% | -6934.80% | -9894.67% |
| AdaptHealth Corp. (AHCO)vs › | $792.17M | -0.31% | 6.92% | 0.39% | 2.91% |
| InMode Ltd. (INMD)vs › | $805.89M | 18.47% | 25.77% | 33.72% | 36.17% |
Gross Margin
66.0%
Operating Margin
9.0%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 11.69% |
| 2026-03-31 | 4.31% |
| 2025-12-31 | 12.25% |
| 2025-09-30 | 7.78% |
| 2025-06-30 | 5.15% |
| 2025-03-31 | 2.36% |
| 2024-12-31 | 9.20% |
| 2024-09-30 | 6.07% |
| 2024-06-30 | 9.59% |
| 2024-03-31 | -460.55% |
| 2023-12-31 | -0.13% |
| 2023-09-30 | -0.11% |
| 2023-06-30 | -1.31% |
| 2023-03-31 | 0.93% |
| 2022-12-31 | 6.27% |
| 2022-09-30 | 6.80% |
| 2022-06-30 | -9.11% |
| 2022-03-31 | -0.19% |
| 2021-12-31 | -4.59% |
| 2021-09-30 | 11.72% |
| 2021-06-30 | 8.94% |
| 2021-03-31 | 11.32% |
| 2020-12-31 | 0.06% |
| 2020-09-30 | 14.03% |
| 2020-06-30 | 11.92% |
| 2020-03-31 | 2.63% |
| 2019-12-31 | -10.28% |
| 2019-09-30 | 18.38% |
| 2019-06-30 | 20.51% |
| 2019-03-31 | 9.68% |
| 2018-12-31 | 4.95% |
| 2018-09-30 | 4.58% |
| 2018-06-30 | 18.95% |
| 2018-03-31 | 24.71% |
| 2017-12-31 | -42.62% |
| 2017-09-30 | 15.89% |
| 2017-06-30 | 8.74% |
| 2017-03-31 | 21.98% |
| 2016-12-31 | 18.40% |
| 2016-09-30 | 16.44% |
| 2016-06-30 | 12.20% |
| 2016-03-31 | 23.55% |
| 2015-12-31 | 19.24% |
| 2015-09-30 | 13.80% |
| 2015-06-30 | 20.06% |
| 2015-03-31 | 22.64% |
| 2014-12-31 | 20.80% |
| 2014-09-30 | 26.43% |
| 2014-06-30 | 18.63% |
| 2014-03-31 | 21.77% |
| 2013-12-31 | 21.39% |
| 2013-09-30 | 19.84% |
| 2013-06-30 | 27.13% |
| 2013-03-31 | 30.69% |
| 2012-12-31 | 21.69% |
| 2012-09-30 | 29.80% |
| 2012-06-30 | 30.49% |
| 2012-03-31 | 27.39% |
| 2011-12-31 | 34.15% |
| 2011-09-30 | 35.37% |
| 2011-06-30 | 30.32% |
| 2011-03-31 | 33.38% |
| 2010-12-31 | 26.16% |
| 2010-09-30 | 29.96% |
| 2010-06-30 | 29.54% |
| 2010-03-31 | 31.60% |
| 2009-12-31 | 34.19% |
| 2009-09-30 | 36.60% |
| 2009-06-30 | 32.31% |
| 2009-03-31 | 38.30% |
| 2008-12-31 | 35.30% |
| 2008-09-30 | 36.87% |
| 2008-06-30 | 30.39% |
| 2008-03-31 | 33.45% |
| 2007-12-31 | 36.58% |
| 2007-09-30 | 39.48% |
| 2007-06-30 | 35.30% |
| 2007-03-31 | 34.15% |
| 2006-12-31 | 30.77% |
| 2006-09-30 | 33.42% |
| 2006-06-30 | 32.53% |
| 2006-03-31 | 35.70% |
| 2005-12-31 | 33.64% |
| 2005-09-30 | 39.55% |
| 2005-06-30 | 32.34% |
| 2005-03-31 | 32.98% |
| 2004-12-31 | 33.20% |
| 2004-09-30 | 35.04% |
| 2004-06-30 | 37.26% |
| 2004-03-31 | 37.12% |
| 2003-12-31 | 34.21% |
| 2003-09-30 | 35.69% |
| 2003-06-30 | 35.26% |
| 2003-03-31 | 32.56% |
| 2002-12-31 | 35.69% |
| 2002-09-30 | 40.32% |